251 related articles for article (PubMed ID: 20951207)
1. Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes.
Kalaitzakis ME; Walls AJ; Pearce RK; Gentleman SM
Neurobiol Dis; 2011 Feb; 41(2):377-84. PubMed ID: 20951207
[TBL] [Abstract][Full Text] [Related]
2. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Tsuboi Y; Uchikado H; Dickson DW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
[TBL] [Abstract][Full Text] [Related]
3. Striatal β-amyloid in dementia with Lewy bodies but not Parkinson's disease.
Halliday GM; Song YJ; Harding AJ
J Neural Transm (Vienna); 2011 May; 118(5):713-9. PubMed ID: 21479514
[TBL] [Abstract][Full Text] [Related]
4. Imaging amyloid deposition in Lewy body diseases.
Gomperts SN; Rentz DM; Moran E; Becker JA; Locascio JJ; Klunk WE; Mathis CA; Elmaleh DR; Shoup T; Fischman AJ; Hyman BT; Growdon JH; Johnson KA
Neurology; 2008 Sep; 71(12):903-10. PubMed ID: 18794492
[TBL] [Abstract][Full Text] [Related]
5. CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia.
Bibl M; Mollenhauer B; Esselmann H; Lewczuk P; Klafki HW; Sparbier K; Smirnov A; Cepek L; Trenkwalder C; Rüther E; Kornhuber J; Otto M; Wiltfang J
Brain; 2006 May; 129(Pt 5):1177-87. PubMed ID: 16600985
[TBL] [Abstract][Full Text] [Related]
6. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T
Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334
[TBL] [Abstract][Full Text] [Related]
7. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
Jellinger KA; Korczyn AD
BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
[TBL] [Abstract][Full Text] [Related]
9. Amyloid PET Imaging in Lewy body disorders.
Donaghy P; Thomas AJ; O'Brien JT
Am J Geriatr Psychiatry; 2015 Jan; 23(1):23-37. PubMed ID: 23831180
[TBL] [Abstract][Full Text] [Related]
10. Clinical correlates of pathology in the claustrum in Parkinson's disease and dementia with Lewy bodies.
Kalaitzakis ME; Pearce RK; Gentleman SM
Neurosci Lett; 2009 Sep; 461(1):12-5. PubMed ID: 19523504
[TBL] [Abstract][Full Text] [Related]
11. Striatal dopamine transporter binding differs between dementia with Lewy bodies and Parkinson's disease with dementia.
Ishizawa K; Fujita Y; Nagashima K; Nakamura T; Shibata M; Kasahara H; Makioka K; Taketomi-Takahashi A; Hirasawa H; Higuchi T; Tsushima Y; Ikeda Y
J Neurol Sci; 2023 Aug; 451():120713. PubMed ID: 37441875
[No Abstract] [Full Text] [Related]
12. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
[TBL] [Abstract][Full Text] [Related]
13. Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?
Jellinger KA; Attems J
Acta Neuropathol; 2006 Sep; 112(3):253-60. PubMed ID: 16804711
[TBL] [Abstract][Full Text] [Related]
14. High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.
Bougea A; Stefanis L; Emmanouilidou E; Vekrelis K; Kapaki E
J Neural Transm (Vienna); 2020 Mar; 127(3):311-322. PubMed ID: 31912280
[TBL] [Abstract][Full Text] [Related]
15. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series.
Geut H; Hepp DH; Foncke E; Berendse HW; Rozemuller JM; Huitinga I; van de Berg WDJ
Acta Neuropathol Commun; 2020 Mar; 8(1):39. PubMed ID: 32216828
[TBL] [Abstract][Full Text] [Related]
16. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.
Edison P; Rowe CC; Rinne JO; Ng S; Ahmed I; Kemppainen N; Villemagne VL; O'Keefe G; Någren K; Chaudhury KR; Masters CL; Brooks DJ
J Neurol Neurosurg Psychiatry; 2008 Dec; 79(12):1331-8. PubMed ID: 18653550
[TBL] [Abstract][Full Text] [Related]
17. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
Colloby SJ; Williams ED; Burn DJ; Lloyd JJ; McKeith IG; O'Brien JT
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1176-85. PubMed ID: 15931516
[TBL] [Abstract][Full Text] [Related]
18. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
[TBL] [Abstract][Full Text] [Related]
19. Brain amyloid and cognition in Lewy body diseases.
Gomperts SN; Locascio JJ; Marquie M; Santarlasci AL; Rentz DM; Maye J; Johnson KA; Growdon JH
Mov Disord; 2012 Jul; 27(8):965-73. PubMed ID: 22693110
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease.
Walker L; Simpson H; Thomas AJ; Attems J
Acta Neuropathol Commun; 2024 Feb; 12(1):28. PubMed ID: 38360761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]